Mingjie Ma
- Endocrinology, Diabetes and Metabolism top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Physiology
- Co-authors
- Shokei Kim‐MitsuyamaNobutaka KoibuchiKen UekawaYu HasegawaKensuke ToyamaDaisuke SuetaTakashi NakagawaBo-Wen Lin
- Topics
- Blood Pressure and Hypertension Studies (4 papers)Neurological Disease Mechanisms and Treatments (3 papers)Circadian rhythm and melatonin (3 papers)
In The Last Decade
Mingjie Ma
16 papers receiving 787 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 303
- Molecular Biology 214
- Cardiology and Cardiovascular Medicine 198
- Surgery 155
- Physiology 113
Countries citing papers authored by Mingjie Ma
This map shows the geographic impact of Mingjie Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjie Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjie Ma more than expected).
Fields of papers citing papers by Mingjie Ma
This network shows the impact of papers produced by Mingjie Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjie Ma. The network helps show where Mingjie Ma may publish in the future.
Co-authorship network of co-authors of Mingjie Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Mingjie Ma. A scholar is included among the top collaborators of Mingjie Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjie Ma. Mingjie Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 66 | |
| 4 | 32 | |
| 5 | 32 | |
| 6 | 35 | |
| 7 | 20 | |
| 8 | 1 | |
| 9 | Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic micebreakdown → | 336 |
| 10 | 23 | |
| 11 | 44 | |
| 12 | 19 | |
| 13 | 25 | |
| 14 | 41 | |
| 15 | 45 | |
| 16 | 30 | |
| 17 | 44 |
About Mingjie Ma
Mingjie Ma is a scholar working on Neurology, Endocrine and Autonomic Systems and Behavioral Neuroscience, having authored 17 papers that have together received 799 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (4 papers), Neurological Disease Mechanisms and Treatments (3 papers) and Circadian rhythm and melatonin (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (303 citations), Neurology (102 citations) and Cardiology and Cardiovascular Medicine (198 citations). Mingjie Ma has collaborated with scholars based in Japan and China. Frequent co-authors include Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Ken Uekawa, Yu Hasegawa, Kensuke Toyama, Daisuke Sueta, Takashi Nakagawa, Bo-Wen Lin, Hiroaki Kusaka and Tetsuji Katayama. Their work appears in journals such as Stroke, Scientific Reports and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.